Differentiating low tumor burden from oligometastatic disease in colorectal cancer: a call for individualized therapeutic approaches

Συγγραφείς: de Grandis, M.C. ¹, Baraibar, I. ^{2, ∗}, Prior, O. ³, Balaguer-Montero, M. ³, Salvà, F. ², Ros, J. ², Rodríguez-Castells, M. ², Tabernero, J. ², Lonardi, S. ¹, Perez-Lopez, R. ^{3, 4}, Élez, E. ²

Πηγή: In ESMO Open August 2025 10(8)

REMARQUES SUR L'ANGLO-NORMAND

Συγγραφείς: Prior, O. H.

Πηγή: Romania, 1923 Jan 01. 49(194), 161-185.

Σύνδεσμος πρόσβασης: https://www.jstor.org/stable/45044512

The effect of pair correlation on the moment of inertia and the collective gyromagnetic ratio of deformed nuclei

Συγγραφείς: Nilsson, S. G., Prior, O.

Θεματικοί όροι: nuclear physics

Περιγραφή αρχείου: application/xml

Σύνδεσμος πρόσβασης: https://zbmath.org/3164543

Cambridge Anglo-Norman Texts

Συγγραφείς: Fawtier, E. C., primary, Prior, O. H., additional

Πηγή: The Modern Language Review. 1926/01/01

Collective gyromagnetic ratios of deformed nuclei

Συγγραφείς: Prior, O., primary, Boehm, F., additional, Nilsson, S.G., additional

Πηγή: Nuclear Physics A. 1968/03/01

Morceaux choisis des penseurs français du XVIe au XIXe siècle

Συγγραφείς: W., J. K., primary, Prior, O. H., additional

Πηγή: Books Abroad. 1932/01/01

A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?

Συγγραφείς: Marta Ligero, Bente Gielen, Victor Navarro, Pablo Cresta Morgado, Olivia Prior, Rodrigo Dienstmann, Paolo Nuciforo, Stefano Trebeschi, Regina Beets-Tan, Evis Sala, Elena Garralda, Raquel Perez-Lopez

Συνεισφορές: Institut Català de la Salut, [Ligero M, Gielen B, Prior O, Perez-Lopez R] Radiomics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Navarro V, Dienstmann R] Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Cresta Morgado P] Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Prostate Cancer Translational Research Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Nuciforo P] Molecular Oncology Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Garralda E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Πηγή: NPJ Precis Oncol
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
npj Precision Oncology, Vol 8, Iss 1, Pp 1-9 (2024)
Ligero, M, Gielen, B, Navarro, V, Cresta Morgado, P, Prior, O, Dienstmann, R, Nuciforo, P, Trebeschi, S, Beets-Tan, R, Sala, E, Garralda, E & Perez-Lopez, R 2024, 'A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking?', npj Precision Oncology, vol. 8, 42. https://doi.org/10.1038/s41698-024-00534-9

Θεματικοί όροι: TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia, 0301 basic medicine, Intel·ligència artificial, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, FENÓMENOS Y PROCESOS::conceptos matemáticos::algoritmos::inteligencia artificial, 3. Good health, DISCIPLINES AND OCCUPATIONS::Health Occupations::Medicine::Radiology, DISEASES::Neoplasms, 03 medical and health sciences, 0302 clinical medicine, ENFERMEDADES::neoplasias, Radiologia mèdica, PHENOMENA AND PROCESSES::Mathematical Concepts::Algorithms::Artificial Intelligence, Perspective, DISCIPLINAS Y OCUPACIONES::profesiones sanitarias::medicina::radiología, Càncer - Immunoteràpia, ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy, RC254-282

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/38383736
https://hdl.handle.net/11351/11112
https://doaj.org/article/49b9928b68a74233b3c504afa90ca7b9
https://findresearcher.sdu.dk/ws/files/281031259/Open_Access_Version.pdf
https://doi.org/10.1038/s41698-024-00534-9
https://portal.findresearcher.sdu.dk/da/publications/5c3c29f7-115e-469c-8913-0f86a2b39d36

Radiomics signature for dynamic monitoring of tumor inflamed microenvironment and immunotherapy response prediction

Συγγραφείς: Kinga Bernatowicz, Ramon Amat, Olivia Prior, Joan Frigola, Marta Ligero, Francesco Grussu, Christina Zatse, Garazi Serna, Paolo Nuciforo, Rodrigo Toledo, Manel Escobar, Elena Garralda, Enriqueta Felip, Raquel Perez-Lopez

Συνεισφορές: Institut Català de la Salut, [Bernatowicz K, Amat R, Prior O, Frigola J, Ligero M, Grussu F, Zatse C, Serna G, Nuciforo P, Toledo R] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Escobar M, Garralda E, Felip E, Perez-Lopez R] Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

Πηγή: J Immunother Cancer
Scientia
Scientia. Dipòsit d'Informació Digital del Departament de Salut
instname
Journal for ImmunoTherapy of Cancer, Vol 13, Iss 1 (2025)

Θεματικοί όροι: Male, Other subheadings::Other subheadings::/therapeutic use, Càncer - Imatgeria, Otros calificadores::Otros calificadores::/uso terapéutico, Medicaments antineoplàstics - Ús terapèutic, DISEASES::Neoplasms, COMPUESTOS QUÍMICOS Y DROGAS::acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antineoplásicos::inmunoterapia antineoplásica, Neoplasms, CHEMICALS AND DRUGS::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agents::Antineoplastic Agents, Immunological, Immunotherapy Biomarkers, Tumor Microenvironment, Humans, FENÓMENOS Y PROCESOS::fenómenos fisiológicos celulares::microambiente celular::microambiente tumoral, Immune Checkpoint Inhibitors, RC254-282, Radiomics, Otros calificadores::Otros calificadores::Otros calificadores::/diagnóstico por imagen, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Other subheadings::Other subheadings::Other subheadings::/diagnostic imaging, Middle Aged, ENFERMEDADES::neoplasias, PHENOMENA AND PROCESSES::Cell Physiological Phenomena::Cellular Microenvironment::Tumor Microenvironment, Càncer - Immunoteràpia, Female, Immunotherapy, Tomography, X-Ray Computed

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: https://pubmed.ncbi.nlm.nih.gov/39800381
http://hdl.handle.net/11351/12807
https://doaj.org/article/b5156977bb144aee8b8a3bbf43ebe032

[Urkunde]

Συγγραφείς: author_1

Συνεισφορές: Prior of the Augustinian choirmaster’s pen Steige in Landau, Prior des Augustiner-Chorherrenstifts Steige in Landau

Διαθεσιμότητα: http://data.europeana.eu/aggregation/europeana/782/object_HUL___URKLEHMANN380S7MIL1
http://data.europeana.eu/item/782/object_HUL___URKLEHMANN380S7MIL1

Urk. Lehmann 382

Συγγραφείς: Prior des Augustiner-Chorherrenstifts Steige in Landau, Prior of the Augustinian choirmaster’s pen Steige in Landau

Πηγή: Universitätsbibliothek Heidelberg

Διαθεσιμότητα: http://data.europeana.eu/aggregation/europeana/07932/diglit_lehm382
http://data.europeana.eu/item/07932/diglit_lehm382

Le Journal du Séducteur / Søren Kierkegaard ; trad. du danois par F. et O. Prior et M. H. Guignot.

Συγγραφείς: Kierkegaard, Søren (1813-1855).

Συνεισφορές: Prior, F., Prior, O., Guignot, M. H., Éditions Gallimard. pbl

Other Title: Forførerens dagbog

Σύνδεσμος πρόσβασης: http://katalog.nukat.edu.pl/lib/item?id=chamo:2174629&theme=nukat

Le journal du séducteur / Søren Kierkegaard ; traduit du danois par F. et O. Prior et M. H. Guignot.

Συγγραφείς: Kierkegaard, Søren (1813-1855).

Συνεισφορές: Guignot, M. H., Prior, O., Prior, F., Éditions Gallimard. pbl

Other Title: Forførerens dagbog

Σύνδεσμος πρόσβασης: http://katalog.nukat.edu.pl/lib/item?id=chamo:1995167&theme=nukat

ON MOMENTS OF INERTIA OF STRONGLY DEFORMED ODD-A NUCLEI

Συνεισφορές: Prior, O

Πηγή: Arkiv Fysik; Vol: 14; Other Information: Orig. Receipt Date: 31-DEC-59

Περιγραφή αρχείου: Medium: X; Size: Pages: 451-71

Σύνδεσμος πρόσβασης: http://www.osti.gov/scitech/biblio/4265912

ON THE ALPHA DECAY OF STRONGLY DEFORMED ODD-A NUCLEI

Συνεισφορές: Prior, O

Πηγή: Arkiv Fysik; Vol: 16; Other Information: Orig. Receipt Date: 31-DEC-59

Περιγραφή αρχείου: Medium: X; Size: Pages: 15-18

Σύνδεσμος πρόσβασης: http://www.osti.gov/scitech/biblio/4201683

Co-clinical CT radiomics pipeline to establish candidate imaging biomarkers for colorectal cancer.

Συγγραφείς: Connor K; Discipline of Physiology, School of Medicine, Trinity College Dublin, Ireland; RCSI Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; National Pre-clinical Imaging Centre, Dublin, Ireland. Electronic address: connorka@tcd.ie., Prior O; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, IIS IR-HUVH, 08035 Barcelona, Spain. Electronic address: oliviaprior@vhio.net., Shiels LP; RCSI Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; National Pre-clinical Imaging Centre, Dublin, Ireland. Electronic address: liamshiels@rcsi.ie., Connolly C; RCSI Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; National Pre-clinical Imaging Centre, Dublin, Ireland. Electronic address: columconnolly@rcsi.ie., Miller IS; RCSI Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; National Pre-clinical Imaging Centre, Dublin, Ireland. Electronic address: iansmiller@gmail.com., Crean R; Department of Surgery, Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address: rorycrean@rcsi.ie., Murphy S; RCSI Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland; National Pre-clinical Imaging Centre, Dublin, Ireland. Electronic address: suzannemmurphy@rcsi.ie., McGuinness G; Disipline of Medical Education, School of Medicine, Trinity College Dublin, Ireland., Monreal C; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, IIS IR-HUVH, 08035 Barcelona, Spain. Electronic address: camilomonreal@vhio.net., Serna G; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, IIS IR-HUVH, 08035 Barcelona, Spain. Electronic address: gserna@vhio.net., Idemudia E; Graduate Entry Medicine, Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address: ehitaidemudia22@rcsi.ie., Eriksen G; Graduate Entry Medicine, Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address: gregoryeriksen22@rcsi.ie., Haworth E; Graduate Entry Medicine, Department of Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address: evinhaworth23@rcsi.ie., Prehn JHM; RCSI Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; National Pre-clinical Imaging Centre, Dublin, Ireland. Electronic address: jprehn@rcsi.ie., Tabernero J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, IIS IR-HUVH, 08035 Barcelona, Spain. Electronic address: jtabernero@vhio.net., Elez E; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, IIS IR-HUVH, 08035 Barcelona, Spain. Electronic address: meelez@vhio.net., O'Farrell AC; RCSI Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; National Pre-clinical Imaging Centre, Dublin, Ireland. Electronic address: aliceofarrell@rcsi.ie., O'Brien D; Department of Neurosurgery, Beaumont Hospital, Dublin, Ireland. Electronic address: davidobrien1@beaumont.ie., Toledo R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, IIS IR-HUVH, 08035 Barcelona, Spain. Electronic address: rtoledo@vhio.net., Nuciforo P; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, IIS IR-HUVH, 08035 Barcelona, Spain. Electronic address: pnuciforo@vhio.net., Butterworth KT; Johnston Cancer Research Centre, Queen's University Belfast, Belfast, UK. Electronic address: k.butterworth@qub.ac.uk., Dienstmann R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, IIS IR-HUVH, 08035 Barcelona, Spain. Electronic address: rdienstmann@vhio.net., Perez-Lopez R; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Hospital Campus, IIS IR-HUVH, 08035 Barcelona, Spain., Byrne AT; RCSI Precision Cancer Medicine Group, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, Dublin, Ireland; National Pre-clinical Imaging Centre, Dublin, Ireland. Electronic address: annettebyrne@rcsi.ie.

Πηγή: European journal of radiology [Eur J Radiol] 2026 Oct; Vol. 203, pp. 113038. Date of Electronic Publication: 2026 Jun 28.

Τύπος έκδοσης: Journal Article

Στοιχεία περιοδικού: Publisher: Elsevier Science Ireland Ltd Country of Publication: Ireland NLM ID: 8106411 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7727 (Electronic) Linking ISSN: 0720048X NLM ISO Abbreviation: Eur J Radiol Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Colorectal Neoplasms*/diagnostic imaging , Colorectal Neoplasms*/drug therapy , Tomography, X-Ray Computed*/methods , Liver Neoplasms*/diagnostic imaging , Liver Neoplasms*/secondary , Radiographic Image Interpretation, Computer-Assisted*/methods , Biomarkers, Tumor*, Radiomics ; Humans ; Sensitivity and Specificity ; Animals ; Reproducibility of Results ; Female ; Mice ; Male ; Treatment Outcome

Simulation-Informed Evaluation of Microvascular Parameter Mapping for Diffusion MR Imaging of Solid Tumours.

Συγγραφείς: Voronova AK; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Department of Biomedicine, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Prior O; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Grigoriou A; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.; Department of Biomedicine, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain., Salvà F; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Elez E; Medical Oncology Service, Vall d'Hebron Barcelona Hospital Campus, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Atlagich LM; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Sala-Llonch R; Department of Biomedicine, Faculty of Medicine, Institut d'Investigacions Biomédiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, Barcelona, Spain., Palombo M; Cardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff University, Cardiff, UK.; School of Computer Science and Informatics, Cardiff University, Cardiff, UK., Fieremans E; Bernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, New York University Grossman School of Medicine, New York, NY, USA., Novikov DS; Bernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, New York University Grossman School of Medicine, New York, NY, USA., Perez-Lopez R; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Grussu F; Radiomics Group, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.

Πηγή: Magnetic resonance in medicine [Magn Reson Med] 2026 Jul; Vol. 96 (1), pp. 387-402. Date of Electronic Publication: 2026 Mar 07.

Τύπος έκδοσης: Journal Article; Research Support, Non-U.S. Gov't

Στοιχεία περιοδικού: Publisher: Wiley Country of Publication: United States NLM ID: 8505245 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-2594 (Electronic) Linking ISSN: 07403194 NLM ISO Abbreviation: Magn Reson Med Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Diffusion Magnetic Resonance Imaging*/methods , Microvessels*/diagnostic imaging , Colorectal Neoplasms*/diagnostic imaging , Image Processing, Computer-Assisted*/methods , Neoplasms*/diagnostic imaging, Image Interpretation, Computer-Assisted/methods ; Humans ; Computer Simulation ; Signal-To-Noise Ratio ; Algorithms

Erratum for: Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer.

Συγγραφείς: Prior O, Macarro C, Navarro V, Monreal C, Ligero M, Garcia-Ruiz A, Serna G, Simonetti S, Braña I, Vieito M, Escobar M, Capdevila J, Byrne AT, Dienstmann R, Toledo R, Nuciforo P, Garralda E, Grussu F, Bernatowicz K, Perez-Lopez R

Πηγή: Radiology. Artificial intelligence [Radiol Artif Intell] 2024 May; Vol. 6 (3), pp. e249001.

Τύπος έκδοσης: Published Erratum

Στοιχεία περιοδικού: Publisher: Radiological Society of North America, Inc Country of Publication: United States NLM ID: 101746556 Publication Model: Print Cited Medium: Internet ISSN: 2638-6100 (Electronic) Linking ISSN: 26386100 NLM ISO Abbreviation: Radiol Artif Intell Subsets: MEDLINE; PubMed not MEDLINE

Identification of Precise 3D CT Radiomics for Habitat Computation by Machine Learning in Cancer.

Συγγραφείς: Prior O; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Macarro C; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Navarro V; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Monreal C; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Ligero M; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Garcia-Ruiz A; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Serna G; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Simonetti S; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Braña I; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Vieito M; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Escobar M; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Capdevila J; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Byrne AT; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Dienstmann R; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Toledo R; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Nuciforo P; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Garralda E; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Grussu F; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Bernatowicz K; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.)., Perez-Lopez R; From the Radiomics Group, Vall d'Hebron Institute of Oncology, Carrer de Natzaret 115-117, Barcelona 08035, Spain (O.P., C. Macarro, C. Monreal, M.L., A.G.R., F.G., K.B., R.P.L.); Oncology Data Science Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (V.N., R.D.); Molecular Pathology Group, Vall d'Hebron Institute of Oncology, Barcelona, Spain (G.S., S.S., P.N.); Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain (I.B., M.V., E.G., J.C.); Molecular Therapeutic Research Unit, Vall d'Hebron Institute of Oncology, Barcelona, Spain (I.B., M.V., E.G., J.C.); Department of Radiology, Vall d'Hebron University Hospital, Barcelona, Spain (M.E.); Biomakers and Clonal Dynamics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain (R.T.); Department of Physiology and Medical Physics, Centre for Systems Medicine, Royal College of Surgeons in Ireland, Dublin, Ireland (A.T.B.); and National Pre-clinical Imaging Centre, Dublin, Ireland (A.T.B.).

Πηγή: Radiology. Artificial intelligence [Radiol Artif Intell] 2024 Mar; Vol. 6 (2), pp. e230118.

Τύπος έκδοσης: Journal Article; Research Support, Non-U.S. Gov't

Στοιχεία περιοδικού: Publisher: Radiological Society of North America, Inc Country of Publication: United States NLM ID: 101746556 Publication Model: Print Cited Medium: Internet ISSN: 2638-6100 (Electronic) Linking ISSN: 26386100 NLM ISO Abbreviation: Radiol Artif Intell Subsets: MEDLINE

Ιατρικοί όροι (MeSH): Lung Neoplasms*/diagnostic imaging , Liver Neoplasms*/diagnostic imaging, Tomography, X-Ray Computed/methods ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Reproducibility of Results ; Radiomics ; Machine Learning